AAAAAA

   
Results: 1-13 |
Results: 13

Authors: Puthalakath, H Villunger, A O'Reilly, LA Beaumont, JG Coultas, L Cheney, RE Huang, DCS Strasser, A
Citation: H. Puthalakath et al., Bmf: A proapoptotic BH3-only protein regulated by interaction with the myosin V actin motor complex, activated by anoikis, SCIENCE, 293(5536), 2001, pp. 1829-1832

Authors: Strasser, A Newton, K O'Reilly, LA Pellegrini, M O'Connor, L Puthalakath, H Cullen, L Tai, L Coultas, L Huang, DCS Villunger, A Bouillet, P Bath, ML Vaux, DL Cory, S Adams, JM Harris, AW
Citation: A. Strasser et al., How, when, and why do lymphocytes die?, IMMUNOLOGIS, 8(1-2), 2000, pp. 22-25

Authors: Villunger, A Huang, DCS Holler, N Tschopp, J Strasser, A
Citation: A. Villunger et al., Fas ligand-induced c-Jun kinase activation in lymphoid cells requires extensive receptor aggregation but is independent of DAXX, and Fas-mediated cell death does not involve DAXX, RIP, or RAIDD, J IMMUNOL, 165(3), 2000, pp. 1337-1343

Authors: Villunger, A O'Reilly, LA Holler, N Adams, J Strasser, A
Citation: A. Villunger et al., Fas ligand, Bcl-2, granulocyte colony-stimulating factor, and p38 mitogen-activated protein kinase: Regulators of distinct cell death and survival pathways in granulocytes, J EXP MED, 192(5), 2000, pp. 647-657

Authors: Spitaler, M Villunger, A Grunicke, H Uberall, F
Citation: M. Spitaler et al., Unique structural and functional properties of the ATP-binding domain of atypical protein kinase C-iota, J BIOL CHEM, 275(43), 2000, pp. 33289-33296

Authors: Bauer, B Krumbock, N Ghaffari-Tabrizi, N Kampfer, S Villunger, A Wilda, M Hameister, H Utermann, G Leitges, M Uberall, F Baier, G
Citation: B. Bauer et al., T cell expressed PKC theta demonstrates cell-type selective function, EUR J IMMUN, 30(12), 2000, pp. 3645-3654

Authors: Villunger, A Strasser, A
Citation: A. Villunger et A. Strasser, The great escape: Is immune evasion required for tumor progression?, NAT MED, 5(8), 1999, pp. 874-875

Authors: Huang, DCS Hahne, M Schroeter, M Frei, K Fontana, A Villunger, A Newton, K Tschopp, J Strasser, A
Citation: Dcs. Huang et al., Activation of Fas by FasL induces apoptosis by a mechanism that cannot be blocked by Bcl-2 or Bcl-x(L), P NAS US, 96(26), 1999, pp. 14871-14876

Authors: Uberall, F Hellbert, K Kampfer, S Maly, K Villunger, A Spitaler, M Mwanjewe, J Baier-Bitterlich, G Baier, G Grunicke, HH
Citation: F. Uberall et al., Evidence that atypical protein kinase C-lambda and atypical protein kinaseC-zeta participate in Ras-mediated reorganization of the F-actin cytoskeleton, J CELL BIOL, 144(3), 1999, pp. 413-425

Authors: Villunger, A Ghaffari-Tabrizi, N Tinhofer, I Krumbock, N Bauer, B Schneider, T Kasibhatla, S Greil, R Baier-Bitterlich, G Uberall, F Green, DR Baier, G
Citation: A. Villunger et al., Synergistic action of protein kinase C theta and calcineurin is sufficientfor Fas ligand expression and induction of a crmA-sensitive apoptosis pathway in Jurkat T cells, EUR J IMMUN, 29(11), 1999, pp. 3549-3561

Authors: Ghaffari-Tabrizi, N Bauer, B Villunger, A Baier-Bitterlich, G Altman, A Utermann, G Uberall, F Baier, G
Citation: N. Ghaffari-tabrizi et al., Protein kinase C theta, a selective upstream regulator of JNK/SAPK and IL-2 promoter activation in Jurkat T cells, EUR J IMMUN, 29(1), 1999, pp. 132-142

Authors: Greil, R Egle, A Villunger, A
Citation: R. Greil et al., On the role and significance of Fas (Apo-1/CD95) ligand (FasL) expression in immune privileged tissues and cancer cells using multiple myeloma as a model, LEUK LYMPH, 31(5-6), 1998, pp. 477

Authors: Villunger, A Strasser, A
Citation: A. Villunger et A. Strasser, Does "death receptor" signaling play a role in tumorigenesis and cancer therapy?, ONCOL RES, 10(11-12), 1998, pp. 541-550
Risultati: 1-13 |